Peter Weber1. 1. Division of Neuropediatrics and Developmental Medicine, University Children's Hospital Basel, University of Basel, Spitalstrasse 33, Basel, Switzerland. Peter.Weber@ukbb.ch
Abstract
INTRODUCTION: Intrathecal baclofen treatment (ITB) is widely used in children with cerebral palsy. Although this treatment effectively reduces spasticity, diverse side effects are reported. CASE REPORT: We report about a boy with severe asphyxia-induced encephalopathy with bilateral cerebral palsy. After starting the intrathecal baclofen treatment, he episodically showed symptoms of severe gastroesophageal reflux with pale skin color, vomiting, massive drooling, acid regurgitation, and reduced well-being. An open ventral semifundoplication was done some years ago to treat a gastroesophageal reflux. These symptomatic episodes occurred strongly dose-dependent and were not observed during the short test procedure. CONCLUSION: For the first time, a strong dose-dependent treatment with ITB was documented as a cause for the above episodes and relapsing re-herniations.
INTRODUCTION: Intrathecal baclofen treatment (ITB) is widely used in children with cerebral palsy. Although this treatment effectively reduces spasticity, diverse side effects are reported. CASE REPORT: We report about a boy with severe asphyxia-induced encephalopathy with bilateral cerebral palsy. After starting the intrathecal baclofen treatment, he episodically showed symptoms of severe gastroesophageal reflux with pale skin color, vomiting, massive drooling, acid regurgitation, and reduced well-being. An open ventral semifundoplication was done some years ago to treat a gastroesophageal reflux. These symptomatic episodes occurred strongly dose-dependent and were not observed during the short test procedure. CONCLUSION: For the first time, a strong dose-dependent treatment with ITB was documented as a cause for the above episodes and relapsing re-herniations.
Authors: Marjanke A Hoving; Elisabeth P M van Raak; Geert H J J Spincemaille; Vivianne H J M van Kranen-Mastenbroek; Maarten van Kleef; Jan Willem Gorter; Johan S H Vles Journal: Eur J Paediatr Neurol Date: 2008-06-30 Impact factor: 3.140
Authors: M R Delgado; D Hirtz; M Aisen; S Ashwal; D L Fehlings; J McLaughlin; L A Morrison; M W Shrader; A Tilton; J Vargus-Adams Journal: Neurology Date: 2010-01-26 Impact factor: 9.910
Authors: Monawat Ngerncham; Douglas C Barnhart; Ramanath N Haricharan; Jeffrey M Roseman; Keith E Georgeson; Carroll M Harmon Journal: J Pediatr Surg Date: 2007-09 Impact factor: 2.545